Shant Vartanian, M.D.

Assistant Professor of Surgery
Division of Vascular & Endovascular Surgery
Interim Chief
Department of Surgery at Zuckerberg San Francisco General

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
Shant.Vartanian@ucsf.edu
Open Popup
  • 1994-98, Stanford University, B.Sc. (HON) Biological Sciences
  • 1999-03, Saint Louis University, Doctor of Medicine
  • 2003-04, University of California, San Francisco, Intern, General Surgery
  • 2004-09, University of California, San Francisco, Resident, General Surgery
  • 2005-07, University of California, San Francisco, Post-Doctoral Research Fellow, Laboratory for Accelerated Vascular Research
  • 2009-10, University of California, San Francisco, Chief Resident, General Surgery
  • 2010-2012, University of California, San Francisco, Fellow, Vascular Surgery
  • American Board of Surgery, 2011
  • Abdominal Aortic Aneurysm
  • Aortic Dissection
  • Carotid Artery Disease
  • Complex Limb Revascularization
  • Critical Limb Ischemia
  • Diabetic Vascular Disease
  • Dialysis Access
  • Endovascular Aneurysm Repair
  • Mesenteric Artery Disease
  • Peripheral Artery Disease
  • Thoracic Aortic Aneurysm
  • Thoracic Outlet Syndrome
  • Comparative effectiveness of endovacular interventions for lower extremity arterial disease
  • Endovascular interventions for acute and chronic aortic conditions

Shant Vartanian, M.D. is an assistant professor in the Division of Vascular and Endovascular Surgery. He has been with UCSF since 2003, completing his residency in General Surgery and a fellowship in Vascular Surgery.

He has played a leading role in the revitalization of the Vascular Surgery program at ZSFG. The rapidly maturing program routinely handles aortic trauma, complex endovascular interventions and is a busy clinical practice offering care for peripheral vascular and venous disorders for San Francisco Health Network (SFHN) patients. Dr. Vartanian started and is the medical director of the Vascular Lab, which performs over 1200 non-invasive diagnostic studies for the ZSFG community annually. His clinical research is focused on comparative effectiveness, quality improvement for dialysis access and innovations in dialysis access delivery.

Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.

Nicole Rich, M.D. 7/2015 - 6/2017
Most recent publications from a total of 15
  1. Hiramoto JS, Fernandez C, Gasper W, Vartanian S, Reilly L, Chuter T. Lower extremity weakness is associated with elevated blood and cerebrospinal fluid glucose levels following multibranched endovascular aortic aneurysm repair. J Vasc Surg. 2016 Nov 19. View in PubMed
  2. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Hiramoto JS, Conte MS. Determinants of Midterm Functional Outcomes and Wound Healing in a Hospital-Based Limb Preservation Program. J Vasc Surg. 2016 Aug; 64(2):546-547. View in PubMed
  3. Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 Jun; 63(6):1563-1573.e2. View in PubMed
  4. Fernandez CC, Sobel JD, Gasper WJ, Vartanian SM, Reilly LM, Chuter TA, Hiramoto JS. Standard off-the-shelf versus custom-made multibranched thoracoabdominal aortic stent grafts. J Vasc Surg. 2016 May; 63(5):1208-15. View in PubMed
  5. Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Apr-May; 49(3-4):69-74. View in PubMed
  6. Vartanian SM, Conte MS. Surgical intervention for peripheral arterial disease. Circ Res. 2015 Apr 24; 116(9):1614-28. View in PubMed
  7. Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42. View in PubMed
  8. Sobel JD, Vartanian SM, Gasper WJ, Hiramoto JS, Chuter TA, Reilly LM. Lower extremity weakness after endovascular aneurysm repair with multibranched thoracoabdominal stent grafts. J Vasc Surg. 2015 Mar; 61(3):623-8. View in PubMed
  9. Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013 Dec; 58(6):1525-31. View in PubMed
  10. Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg. 2012 Oct; 56(4):998-1006, 1007.e1; discussion 1006-7. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Shant Vartanian, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X